Visualizing implanted tumors in mice with magnetic resonance imaging using magnetotactic bacteria

Area of Science:

• Biomedical Engineering
• Microbiology
• Medical Imaging

Background:

• Magnetotactic bacteria (MTB) naturally produce magnetic nanoparticles.
• Developing novel contrast agents for medical imaging is crucial for early disease detection.
• Targeted delivery of imaging agents to tumors can improve diagnostic accuracy.

Purpose of the Study:

• To evaluate the potential of Magnetospirillum magneticum AMB-1 as a positive contrast agent for magnetic resonance imaging (MRI).
• To determine if AMB-1 can specifically target and colonize tumors in vivo.
• To assess the safety and efficacy of AMB-1 for tumor visualization.

Main Methods:

• In vitro and in vivo studies using Magnetospirillum magneticum AMB-1.
• Manipulation of bacterial growth to produce small magnetite particles.
• Intravenous and intratumoral injection of bacteria in mouse models.
• Positron emission tomography (PET) imaging with 64Cu-labeled bacteria.
• Transmission electron microscopy (TEM) for particle visualization.
• Magnetic resonance imaging (MRI) for contrast enhancement.
• Viable cell counts to assess bacterial distribution.

Main Results:

• AMB-1 bacteria produced T1-weighted positive contrast, enhancing MRI visualization.
• PET imaging and cell counts confirmed tumor-specific colonization and clearance from other organs by day 6.
• MRI showed a significant increase in positive contrast in tumors on days 2 and 6 post-injection.
• No adverse effects were observed in the tested mouse models.

Conclusions:

• Magnetotactic bacteria (AMB-1) can be engineered to produce positive MRI contrast.
• AMB-1 demonstrates effective tumor targeting and colonization in preclinical models.
• This approach offers a promising new tool for enhanced MRI visualization in cancer research and diagnostics.